CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹34 Cr | ₹28 Cr | ₹23 Cr | ₹21 Cr | ₹17 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CONCORD BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹28 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹21 Cr |
| Mar2021 | ₹17 Cr |
How is Deferred Tax Assets / Liabilities of CONCORD BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 21.23 | |
| Mar2024 | ₹28 Cr | 19.74 | |
| Mar2023 | ₹23 Cr | 11.77 | |
| Mar2022 | ₹21 Cr | 20.16 | |
| Mar2021 | ₹17 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹11,926.0 Cr | 12.2% | 12.4% | -28.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 12.2% |
12.4% |
-28.8% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses